Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe
Takaaki Matsuoka, Takaaki Itohara, Yurie Hara, Nana Kobayashi, Lindsay A Farrer · 2024
Read Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe by Takaaki Matsuoka, Takaaki Itohara, Yurie Hara, Nana Kobayashi, Lindsay A Farrer (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642704.txt.
Description
Takaaki Matsuoka and co-authors report a safety study from two thousand twenty-four on stem cell therapy given through a vein. The cells, called mesenchymal stem cells, were taken from each patient's own fat tissue. Such cells draw interest for repair and for age-related frailty, but long-term safety in humans needed more data.
The team reviewed more than two thousand five hundred patients treated at one Tokyo clinic over about nine years. Doses ranged widely, with most patients receiving one to two billion cells. Major heart and brain events were very rare, and no severe side effects were reported. Minor events were uncommon. Age, not dose or sex, linked to the few major events. The authors conclude the treatment was safe in this group.
Catalog record
| CREATOR | Takaaki Matsuoka, Takaaki Itohara, Yurie Hara, Nana Kobayashi, Lindsay A Farrer |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |